NYSE - Delayed Quote USD
GSK plc (GSK)
37.17
-0.33
(-0.88%)
At close: May 7 at 4:00:02 PM EDT
36.81
-0.36
(-0.97%)
After hours: May 7 at 7:49:51 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 4 |
| Avg. Estimate | 1.15 | 1.34 | 4.35 | 4.83 |
| Low Estimate | 1.1 | 1.28 | 4.26 | 4.48 |
| High Estimate | 1.2 | 1.39 | 4.44 | 5.03 |
| Year Ago EPS | 1.11 | 1.29 | 3.98 | 4.35 |
Revenue Estimate
| Currency in GBP | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 12 | 19 |
| Avg. Estimate | 7.93B | 8.24B | 32.34B | 34.15B |
| Low Estimate | 7.72B | 8.02B | 31.83B | 32.84B |
| High Estimate | 8.29B | 8.38B | 33.02B | 35.86B |
| Year Ago Sales | 7.88B | 8.01B | 31.38B | 32.34B |
| Sales Growth (year/est) | 0.61% | 2.86% | 3.08% | 5.59% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.98 | 1.16 | 0.49 | 1.04 |
| EPS Actual | 1.11 | 1.29 | 0.58 | 1.2 |
| Difference | 0.13 | 0.13 | 0.09 | 0.16 |
| Surprise % | 13.17% | 10.97% | 18.80% | 15.64% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.15 | 1.34 | 4.35 | 4.83 |
| 7 Days Ago | 1.12 | 1.34 | 4.34 | 4.81 |
| 30 Days Ago | 1.05 | 1.21 | 4.26 | 4.68 |
| 60 Days Ago | 1.05 | 1.21 | 4.26 | 4.66 |
| 90 Days Ago | 0.96 | 1.06 | 4.05 | 4.5 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 1 | -- |
| Up Last 30 Days | 2 | -- | 2 | 4 |
| Down Last 7 Days | -- | 1 | 1 | 2 |
| Down Last 30 Days | -- | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GSK | 3.29% | 3.31% | 9.38% | 11.11% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Downgrade | Jefferies: Buy to Hold | 11/12/2024 |
| Downgrade | Guggenheim: Buy to Neutral | 10/31/2024 |
| Downgrade | UBS: Buy to Neutral | 7/8/2024 |
| Maintains | Jefferies: Buy to Buy | 7/2/2024 |
| Initiated | Goldman Sachs: Neutral | 5/30/2024 |
| Upgrade | Guggenheim: Neutral to Buy | 3/4/2024 |
Related Tickers
AZN AstraZeneca PLC
70.07
-0.27%
SNY Sanofi
52.27
-1.66%
BMY Bristol-Myers Squibb Company
47.62
+0.11%
NVS Novartis AG
111.70
+1.04%
MRK Merck & Co., Inc.
79.12
+0.10%
AMGN Amgen Inc.
275.84
+2.00%
GILD Gilead Sciences, Inc.
98.90
+1.04%
PFE Pfizer Inc.
22.79
-0.39%
BIIB Biogen Inc.
117.21
+0.33%
OGN Organon & Co.
8.76
-4.05%